Health

Alopecia Market Forecast, Revenue, Demand, Growth and Key Companies Valuation by 2028

September 8, 2021

The global alopecia market is projected to be worth USD 5,250.8 Million by 2027, according to a current analysis by Emergen Research. The report provides Alopecia market forecast, supported by detailed insights historical data and revenues, past and current market trends, industry trends, consumer trends, market size, market share, market growth, along with ranging impacts of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2024–2028. The report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials. The alopecia market is projected to experience rapid growth by the year 2027. The rising occurrence of alopecia is a significant factor driving the growth of the market. Additionally, various chronic disorders and genetic diseases may be causative of hair loss/alopecia in people. Male pattern baldness, a hereditary cause of hair loss, may be triggered at any point in a man’s life, including adolescence.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/175

Growing trends in hair fashion put a lot of unwanted stress on the hair follicles leading to traumatic alopecia, and in turn, driving the market growth. Global Alopecia market forecast has been provided following thorough study, focus, comparison, and analysis of a varying range of factors and past market forecast and present outcomes. Alopecia Market forecast is made possible through, but has not been limited to, a study and analysis of a variety of factors and trends, and these are verified through interviews with industry experts and companies operating in the market. The disease’s likely occurrence is about 0.001% of the population and has a lifetime risk of around 2.0%. It may occur in people of all ages, including children and adults, and at more or less the same rate in the male and female population. Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the Alopecia market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive Alopecia market revenue growth to a significant extent over the forecast period.

Browse Full Report Description with TOC@ https://www.emergenresearch.com/industry-report/alopecia-market

Emergen Research has segmented the global alopecia market on the basis of type, application, end-users, distribution channel, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)
- Alopecia Areata
- Androgenetic Alopecia
- Alopecia Totalis
- Traction Alopecia
- Cicatricle Alopecia
- Others

Application Outlook (Revenue, USD Billion; 2017-2027)
- Male
- Female

End-Users Outlook (Revenue, USD Billion; 2017-2027)
- Dermatology Clinics
- Homecare Settings
- Others

Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
- Prescription
- OTC (Over-the-Counter)

Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
  1. U.S.
  2. Canada
  3. Mexico
- Europe
  1. Germany
  2. UK
  3. France
  4. BENELUX
  5. Rest of Europe
- Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. Rest of APAC
- Latin America
  1. Brazil
  2. Rest of LATAM
- MEA
  1. Saudi Arabia
  2. UAE
  3. Rest of MEA

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Alopecia Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2024 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Key Highlights From The Report

In January 2024, Revian made an announcement about the receiving of a patent by the U.S. Patent & Trademark Office (USPTO) for the application of proprietary color light combinations for regenerating living body tissues such as including hair.
Androgenetic alopecia is likely to grow at the fastest rate in the period 2024-2027. It is a commonly occurring hair loss in the global population. In the case of men, it is also referred to as male-pattern baldness.
Alopecia totalis causes total hair loss on the scalp and is considered an advanced form of alopecia areata responsible for round hair loss patches.
PCO (Polycystic Ovary Syndrome) is responsible for androgenic alopecia in females worldwide with an anticipated 20.0% of females witnessing the condition before menopause and around 40.0% post-menopause.
The OTC (over-the-counter) availability of alopecia treatment drugs is fueled by rising focus to provide easy therapeutic accessibility and the necessity for affordable treatment.
The market in the Asia Pacific region is projected to grow at the fastest rate of 10.0% in the forecast period attributed to increasing incidence of chronic disorders, growing awareness among the population, especially in people of the young generation, and a rise in the level of disposable income.
Key participants include Johnson & Johnson Services Inc., Cirrus Hair Centers, Cipla Inc., Follica Inc., Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Concert Pharmaceuticals Inc., GlaxoSmithKline PLC, Aclaris Therapeutics Inc., and HCell Inc., among others.

Request customized copy of Alopecia report@ https://www.emergenresearch.com/request-for-customization/175

Region wise performance of the Alopecia industry

North America Alopecia market forecast is expected to remain significantly positive in terms of revenue share between 2024 and 2028. In addition, North America Alopecia market revenue share is expected to remain comparatively larger than that of other regional markets from 2024 to 2028.

Asia Pacific registered fastest revenue CAGR in 2024, and the Alopecia market forecast is that this trend is expected to continue going ahead. Market forecast states that revenue share contribution from China, India, and South Korea is expected to remain robust till 2028.

Europe Alopecia market forecast is positive currently, with revenue growth expected to remain steady between 2024 and 2028. Robust focus on research and development initiatives by major firms and changing trends and demographics in countries in the region are some factors expected to continue to support Alopecia market growth.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Table of Content

Chapter 1. Methodology & Sources

1.1. Alopecia Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Alopecia Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2024-2028

Chapter 3. Key Insights

Chapter 4. Alopecia Market Segmentation & Impact Analysis

4.1. Alopecia Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Alopecia Market indicators analysis

4.2.2. Alopecia Market drivers analysis

4.2.2.1. Rapid urbanization and industrialization

4.2.2.2. Stringent government regulations regarding carbon emissions

4.2.2.3. Increasing prevalence of respiratory diseases

4.2.2.4. Rising need to enhance indoor air quality

4.2.3. Alopecia Market restraints analysis

4.2.3.1. High cost associated with the maintenance of Alopecia products

4.2.3.2. Availability of renewable sources of energy

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Chapter 10. Competitive Landscape

10.1. Alopecia Market Revenue Share By Manufacturers

10.2. Mergers & Acquisitions

10.3. Competitor’s Positioning

10.4. Strategy Benchmarking

10.5. Vendor Landscape

10.5.1. Raw Material Suppliers

10.5.1.1. North America

10.5.1.2. Europe

10.5.1.3. Asia Pacific

10.5.1.4. Middle East & Africa

10.5.1.5. Latin America

10.5.2. Distributors

10.5.2.1. North America

10.5.2.2. Europe

10.5.2.3. Asia Pacific

10.5.2.4. Middle East & Africa

10.5.2.5. Latin America

10.5.3. Others

Continued….

Avail Discount on Alopecia Market Report@ https://www.emergenresearch.com/request-discount/175

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Alopecia industry for the forecast period 2024-2027?
What are the major driving forces expected to impact the development of the Alopecia market across different regions?
Who are the major driving forces expected to decide the fate of the Alopecia industry worldwide?
Who are the prominent market players making a mark in the Alopecia market with their winning strategies?
Which Alopecia industry trends are likely to shape the future of the industry during the forecast period 2024-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Alopecia market?

Why Choose Emergen Research?